{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T07:06:17Z","timestamp":1791183977463,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"25","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Federal Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"German Center for Infection Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.085","type":"journal-article","created":{"date-parts":[[2014,4,14]],"date-time":"2014-04-14T20:15:26Z","timestamp":1397506526000},"page":"2980-2988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["The adjuvant component \u03b1-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy"],"prefix":"10.1016","volume":"32","author":[{"given":"Sanita","family":"Masoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ploen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Kunz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Hildt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2014.03.085_bib0005","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2014.03.085_bib0010","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.03.085_bib0015","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.conb.2013.04.013","article-title":"The autoimmune basis of narcolepsy","volume":"23","author":"Mahlios","year":"2013","journal-title":"Curr Opin Neurobiol"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2014.03.085_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/sleep\/30.1.13","article-title":"The epidemiology of narcolepsy","volume":"30","author":"Longstreth","year":"2007","journal-title":"Sleep"},{"issue":"Apr (2)","key":"10.1016\/j.vaccine.2014.03.085_bib0025","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.smrv.2007.07.010","article-title":"Narcolepsy: immunological aspects","volume":"12","author":"Overeem","year":"2008","journal-title":"Sleep Med Rev"},{"issue":"Mar (3)","key":"10.1016\/j.vaccine.2014.03.085_bib0030","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1748-1716.2009.02012.x","article-title":"Hypocretin\/orexin and narcolepsy: new basic and clinical insights","volume":"198","author":"Nishino","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"issue":"Mar (5)","key":"10.1016\/j.vaccine.2014.03.085_bib0035","first-page":"1","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"issue":"Dec (6)","key":"10.1016\/j.vaccine.2014.03.085_bib0040","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.conb.2011.09.003","article-title":"Narcolepsy with hypocretin\/orexin deficiency, infections and autoimmunity of the brain","volume":"21","author":"Kornum","year":"2011","journal-title":"Curr Opin Neurobiol"},{"issue":"Feb (7)","key":"10.1016\/j.vaccine.2014.03.085_bib0045","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1073\/pnas.0308458100","article-title":"Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy","volume":"101","author":"Siebold","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Jul (10)","key":"10.1016\/j.vaccine.2014.03.085_bib0050","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1096\/fasebj.13.10.1145","article-title":"Vitamin E: function and metabolism","volume":"13","author":"Brigelius-Flohe","year":"1999","journal-title":"FASEB J"},{"issue":"Oct (4)","key":"10.1016\/j.vaccine.2014.03.085_bib0055","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1189\/jlb.0108023","article-title":"Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention","volume":"84","author":"Wu","year":"2008","journal-title":"J Leukoc Biol"},{"issue":"Apr (4)","key":"10.1016\/j.vaccine.2014.03.085_bib0060","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/ajcn\/67.4.669","article-title":"Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E","volume":"67","author":"Burton","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"Jun (6)","key":"10.1016\/j.vaccine.2014.03.085_bib0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/nu4060467","article-title":"Plasma and tissue concentrations of alpha-tocopherol and delta-tocopherol following high dose dietary supplementation in mice","volume":"4","author":"Baxter","year":"2012","journal-title":"Nutrients"},{"issue":"Mar 2","key":"10.1016\/j.vaccine.2014.03.085_bib0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jconrel.2010.11.013","article-title":"Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology","volume":"150","author":"Mittal","year":"2011","journal-title":"J Control Release"},{"issue":"Mar (13)","key":"10.1016\/j.vaccine.2014.03.085_bib0075","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.vaccine.2011.01.011","article-title":"Adjuvant system AS03 containing alpha-tocopherol modulates innate immune response and leads to improved adaptive immunity","volume":"29","author":"Morel","year":"2011","journal-title":"Vaccine"},{"issue":"Dec (12)","key":"10.1016\/j.vaccine.2014.03.085_bib0080","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jnutbio.2009.10.010","article-title":"alpha-Tocopherol is an effective Phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells","volume":"21","author":"Feng","year":"2010","journal-title":"J Nutr Biochem"},{"issue":"Feb","key":"10.1016\/j.vaccine.2014.03.085_bib0085","first-page":"36","article-title":"Regulation of Nrf2: an update","volume":"66","author":"Niture","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.vaccine.2014.03.085_bib0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","article-title":"Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway","volume":"47","author":"Kensler","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"Dec (23)","key":"10.1016\/j.vaccine.2014.03.085_bib0095","doi-asserted-by":"crossref","first-page":"8786","DOI":"10.1128\/MCB.23.23.8786-8794.2003","article-title":"Antioxidants enhance mammalian proteasome expression through the Keap1-Nrf2 signaling pathway","volume":"23","author":"Kwak","year":"2003","journal-title":"Mol Cell Biol"},{"issue":"Jul (4)","key":"10.1016\/j.vaccine.2014.03.085_bib0100","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/j.bbrc.2006.05.043","article-title":"Induction of 26S proteasome subunit PSMB5 by the bifunctional inducer 3-methylcholanthrene through the Nrf2-ARE, but not the AhR\/Arnt-XRE, pathway","volume":"345","author":"Kwak","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"issue":"Dec (52)","key":"10.1016\/j.vaccine.2014.03.085_bib0105","doi-asserted-by":"crossref","first-page":"41074","DOI":"10.1074\/jbc.M110.145862","article-title":"Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2","volume":"285","author":"Schaedler","year":"2010","journal-title":"J Biol Chem"},{"issue":"Dec (12)","key":"10.1016\/j.vaccine.2014.03.085_bib0110","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1016\/j.cellsig.2013.08.007","article-title":"Redox activation of Nrf2 & NF-kappaB: a double end sword?","volume":"25","author":"Buelna-Chontal","year":"2013","journal-title":"Cell Signal"},{"issue":"Sep","key":"10.1016\/j.vaccine.2014.03.085_bib0115","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.brainres.2012.07.052","article-title":"The protection by octreotide against experimental ischemic stroke: up-regulated transcription factor Nrf2, HO-1 and down-regulated NF-kappaB expression","volume":"1475","author":"Chen","year":"2012","journal-title":"Brain Res"},{"issue":"Mar (11)","key":"10.1016\/j.vaccine.2014.03.085_bib0120","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1074\/jbc.M110.186684","article-title":"Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small Maf proteins","volume":"286","author":"Carvajal-Yepes","year":"2011","journal-title":"J Biol Chem"},{"issue":"May (10)","key":"10.1016\/j.vaccine.2014.03.085_bib0125","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/MCB.26.10.3773-3784.2006","article-title":"Nrf transcription factors in keratinocytes are essential for skin tumor prevention but not for wound healing","volume":"26","author":"auf dem Keller","year":"2006","journal-title":"Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.vaccine.2014.03.085_bib0130","first-page":"179","article-title":"Polyethylenimine, a cost-effective transfection reagent","volume":"6","author":"Ehrhardt","year":"2006","journal-title":"Ref Type: Generic"},{"issue":"Jan (2)","key":"10.1016\/j.vaccine.2014.03.085_bib0135","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.febslet.2005.12.071","article-title":"Raf-1 kinase associates with Hepatitis C virus NS5A and regulates viral replication","volume":"580","author":"Burckstummer","year":"2006","journal-title":"FEBS Lett"},{"issue":"Jan (1)","key":"10.1016\/j.vaccine.2014.03.085_bib0140","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/sj.emboj.7601950","article-title":"Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin\/IGF-1 resistance","volume":"27","author":"Beyer","year":"2008","journal-title":"EMBO J"},{"issue":"Nov (3)","key":"10.1016\/j.vaccine.2014.03.085_bib0145","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)81375-6","article-title":"Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death","volume":"87","author":"Liu","year":"1996","journal-title":"Cell"},{"issue":"Oct (43)","key":"10.1016\/j.vaccine.2014.03.085_bib0150","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1016\/j.vaccine.2011.08.016","article-title":"Safety of pandemic H1N1 vaccines in children and adolescents","volume":"29","author":"Wijnans","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.085_bib0155","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"issue":"Nov (49)","key":"10.1016\/j.vaccine.2014.03.085_bib0160","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/j.vaccine.2012.09.032","article-title":"Autoimmune disorders after immunisation with influenza A\/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review","volume":"30","author":"Isai","year":"2012","journal-title":"Vaccine"},{"issue":"Dec (216)","key":"10.1016\/j.vaccine.2014.03.085_bib0165","doi-asserted-by":"crossref","first-page":"216ra176","DOI":"10.1126\/scitranslmed.3007762","article-title":"CD4+ T cell autoimmunity to hypocretin\/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy","volume":"5","author":"De la Herran-Arita","year":"2013","journal-title":"Sci Transl Med"},{"issue":"Mar (2)","key":"10.1016\/j.vaccine.2014.03.085_bib0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/MOG.0b013e328324f857","article-title":"Nuclear factor-kappa B in intestinal protection and destruction","volume":"25","author":"Spehlmann","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"issue":"Aug (2)","key":"10.1016\/j.vaccine.2014.03.085_bib0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-3083.2011.02561.x","article-title":"Pandemic influenza vaccination elicits influenza-specific CD4+ Th1-cell responses in hypogammaglobulinaemic patients: four case reports","volume":"74","author":"Pedersen","year":"2011","journal-title":"Scand J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004769?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004769?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T01:13:58Z","timestamp":1572311638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":35,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004769"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adjuvant component \u03b1-tocopherol triggers via modulation of Nrf2 the expression and turnover of hypocretin in vitro and its implication to the development of narcolepsy","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}